S&P 500 Futures
(0.41%) 5 175.75 points
Dow Jones Futures
(0.37%) 38 976 points
Nasdaq Futures
(0.32%) 18 059 points
Oil
(0.81%) $78.74
Gas
(2.24%) $2.19
Gold
(0.68%) $2 324.30
Silver
(2.32%) $27.31
Platinum
(0.74%) $972.40
USD/EUR
(-0.17%) $0.927
USD/NOK
(-0.55%) $10.81
USD/GBP
(-0.33%) $0.794
USD/RUB
(-0.33%) $91.15

实时更新: Indoco Remedies Limited [INDOCO.NS]

交易所: NSE 部门: Healthcare 工业: Drug Manufacturers—Specialty & Generic
最后更新时间6 May 2024 @ 17:59

-0.64% INR 335.55

Live Chart Being Loaded With Signals

Commentary (6 May 2024 @ 17:59):

Indoco Remedies Limited manufactures and sells formulations and active pharmaceutical ingredients in India and internationally. The company offers respiratory products, such as Karvol Plus, Febrex Plus, and Tuspel; stomatologicals products that include Sensodent-K, Sensoform Toothpaste, Sensoform Gum Paint, Rexidin M, Rexidin SRS, RR Sensoform Dental, Snowdent, Kidodent, Rexidin Plus, and Dentogel; gastrointestinal products, such as Carmicide, Cyclopam, Cyclomeff, and Nosic; pain/analgesics products that include Lignox and T-lac; and ophthal/otologicals products, such as Renolen, Homide, Dexoren – S, Zincoren, Otorex, Mofloren-D, and Mofloren LP...

Stats
今日成交量 403 807
平均成交量 100 189
市值 30.93B
EPS INR0 ( 2024-01-23 )
下一个收益日期 ( INR2.80 ) 2024-05-21
Last Dividend INR2.25 ( 2023-09-18 )
Next Dividend INR0 ( N/A )
P/E 30.48
ATR14 INR0.403 (0.12%)

音量 相关性

長: 0.11 (neutral)
短: 0.81 (strong)
Signal:(58.671) Same movement expected

Indoco Remedies Limited 相关性

10 最负相关
SICAGEN.NS-0.883
SMLT.NS-0.881
OIL.NS-0.875
STAMPEDE.NS-0.873
STERTOOLS.NS-0.871
NEWGEN.NS-0.871
KEERTI.NS-0.869
SURYAROSNI.NS-0.863
ROTO.NS-0.862
PDSMFL.NS-0.856

你知道吗?

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。

相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Indoco Remedies Limited 相关性 - 货币/商品

The country flag -0.23
( neutral )
The country flag 0.01
( neutral )
The country flag 0.12
( neutral )
The country flag 0.00
( neutral )
The country flag 0.29
( neutral )
The country flag -0.10
( neutral )

Indoco Remedies Limited 财务报表

Annual 2022
营收: INR16.40B
毛利润: INR11.19B (68.21 %)
EPS: INR15.44
FY 2022
营收: INR16.40B
毛利润: INR11.19B (68.21 %)
EPS: INR15.44
FY 2022
营收: INR15.04B
毛利润: INR10.40B (69.16 %)
EPS: INR16.80
FY 2021
营收: INR12.19B
毛利润: INR8.59B (70.49 %)
EPS: INR10.10

Financial Reports:

No articles found.

Indoco Remedies Limited Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
INR0.750
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR2.25
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)

Indoco Remedies Limited Dividend Information - Dividend Junior

Dividend Sustainability Score: 2.93 - low (50.00%) | Divividend Growth Potential Score: 3.59 - Decrease likely (28.19%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend INR0.667 2005-09-15
Last Dividend INR2.25 2023-09-18
Next Dividend INR0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 21 --
Total Paid Out INR20.23 --
Avg. Dividend % Per Year 0.26% --
Score 1.79 --
Div. Sustainability Score 2.93
Div.Growth Potential Score 3.59
Div. Directional Score 3.26 --
Next Divdend (Est)
(2024-05-20)
INR2.51 Estimate 3.18 %
Dividend Stability
0.25 Very Poor
Dividend Score
1.79
Pay Frequency
Annually
Yearly Payout
Year Amount Yield
2005 INR0 0.00%
2006 INR0 0.00%
2007 INR0 0.00%
2008 INR0 0.00%
2009 INR0 0.00%
2010 INR0 0.00%
2011 INR0 0.00%
2012 INR0 0.00%
2013 INR0 0.00%
2014 INR0 0.00%
2015 INR0 0.00%
2016 INR0 0.00%
2017 INR0 0.00%
2018 INR1.000 0.52%
2019 INR0.300 0.14%
2020 INR0.300 0.16%
2021 INR1.500 0.49%
2022 INR0.750 0.17%
2023 INR2.25 0.55%
2024 INR0 0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
POLYPLEX.NS Dividend Knight 2023-09-08 Semi-Annually 22 5.28%
JSWSTEEL.NS Dividend Junior 2023-07-11 Annually 20 1.70%
DOLLAR.NS Dividend Junior 2023-07-27 Annually 8 0.54%
AARVI.NS Dividend Knight 2023-09-15 Annually 7 1.38%
SPAL.NS Dividend Junior 2023-09-15 Sporadic 8 0.44%
MOTHERSON.NS Dividend Junior 2023-08-11 Annually 23 0.63%
HERITGFOOD.NS Dividend Junior 2023-08-14 Annually 23 0.44%
BIKAJI.NS Dividend Junior 2023-06-08 Insufficient data to determine frequency 2 0.06%
RANEHOLDIN.NS Dividend Junior 2023-07-27 Annually 21 0.95%
KOPRAN.NS Dividend Junior 2023-09-07 Annually 5 1.18%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.05711.5008.8610.00[0 - 0.5]
returnOnAssetsTTM01.20000[0 - 0.3]
returnOnEquityTTM0.09691.500-0.0350-0.0524[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM00.800-5.00-4.00[1 - 3]
quickRatioTTM00.800-4.71-3.76[0.8 - 2.5]
cashRatioTTM01.500-1.111-1.667[0.2 - 2]
debtRatioTTM0-1.50000[0 - 0.6]
interestCoverageTTM5.331.0009.149.14[3 - 30]
operatingCashFlowPerShareTTM14.322.005.2310.00[0 - 30]
freeCashFlowPerShareTTM14.322.002.845.68[0 - 20]
debtEquityRatioTTM0-1.50000[0 - 2.5]
grossProfitMarginTTM0.6911.0001.8201.820[0.2 - 0.8]
operatingProfitMarginTTM0.1041.0009.929.92[0.1 - 0.6]
cashFlowToDebtRatioTTM01.000-1.111-1.111[0.2 - 2]
assetTurnoverTTM00.800-3.33-2.67[0.5 - 2]
Total Score2.93

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM30.221.0007.050[1 - 100]
returnOnEquityTTM0.09692.50-0.0225-0.0524[0.1 - 1.5]
freeCashFlowPerShareTTM14.322.005.235.68[0 - 30]
dividendYielPercentageTTM0.6751.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM14.322.005.2310.00[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM0.4561.500-0.2970[0.5 - 2]
operatingCashFlowSalesRatioTTM0.07421.000-0.6450[0.1 - 0.5]
Total Score3.59

Indoco Remedies Limited

Indoco Remedies Limited manufactures and sells formulations and active pharmaceutical ingredients in India and internationally. The company offers respiratory products, such as Karvol Plus, Febrex Plus, and Tuspel; stomatologicals products that include Sensodent-K, Sensoform Toothpaste, Sensoform Gum Paint, Rexidin M, Rexidin SRS, RR Sensoform Dental, Snowdent, Kidodent, Rexidin Plus, and Dentogel; gastrointestinal products, such as Carmicide, Cyclopam, Cyclomeff, and Nosic; pain/analgesics products that include Lignox and T-lac; and ophthal/otologicals products, such as Renolen, Homide, Dexoren – S, Zincoren, Otorex, Mofloren-D, and Mofloren LP. It also provides vitamins/minerals/nutrients that include Methycal, Cital UTI, SM Fibro, Cal Aid, SM Fibro, MCBM DHA, and Apispur; urology products, such as Carmicide and Cital; Cloben G and Scabex for dermatology; ATM for anti-infectives; Hemsyl for blood related; MCBM 69 and D Chiro for gynecological; and Spear for anti-haemorrhoidal. In addition, the company provides analytical services, such as impurity profile, particle size analysis, heavy metal analysis, polymorphism and compatibility studies, extractables and leachables studies, lyophilization studies, reference and working standards, forced degradation studies, and chromatographic method development and validation services. Further, it offers services that include architectural design, lighting, mechanical and utility engineering, project and construction management, electrical, control system, piping, structural design, data transfer system, and process engineering. The company serves general practitioners, pediatricians, consultant physicians, dentists, cardiologists, diabetologists, endocrinologists, gynaecologists, and ophthalmologists. The company was formerly known as Indo Continental Trading Company. Indoco Remedies Limited was founded in 1945 and is based in Mumbai, India.

关于 实时信号

此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。

实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。